Enterprise Value

0.00

Cash

52.2M

Avg Qtr Burn

N/A

Short % of Float

1.87%

Insider Ownership

12.20%

Institutional Own.

0.02%

Qtr Updated

12/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
ONCR-177 Details
Solid tumor/s, Melanoma, Cancer, Breast cancer, Head and neck squamous cell carcinoma

Failed

Discontinued